A pilot study of the functionality and clinician acceptance of a clinical decision support tool to improve primary care of opioid use disorder

  • Rebecca C. Rossom
  • , Jo Ann M. Sperl-Hillen
  • , Patrick J. O’Connor
  • , A. Lauren Crain
  • , Laurel Nightingale
  • , Anne Pylkas
  • , Kristen V. Huntley
  • , Gavin Bart

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Objective: Most Americans with opioid use disorder (OUD) do not receive indicated medical care. A clinical decision support (CDS) tool for primary care providers (PCPs) could address this treatment gap. Our primary objective was to build OUD-CDS tool and demonstrate its functionality and accuracy. Secondary objectives were to achieve high use and approval rates and improve PCP confidence in diagnosing and treating OUD. Methods: A convenience sample of 55 PCPs participated. Buprenorphine-waivered PCPs (n = 8) were assigned to the intervention. Non-waivered PCPs (n = 47) were randomized to intervention (n = 24) or control (n = 23). Intervention PCPs received access to the OUD-CDS, which alerted them to patients at potentially increased risk for OUD or overdose and guided diagnosis and treatment. Control PCPs provided care as usual. Results: The OUD-CDS was functional and accurate following extensive multi-phased testing. PCPs used the OUD-CDS in 5% of encounters with at-risk patients, far less than the goal of 60%. OUD screening confidence increased for all intervention PCPs and OUD diagnosis increased for non-waivered intervention PCPs. Most PCPs (65%) would recommend the OUD-CDS and found it helpful with screening for OUD and discussing and prescribing OUD medications. Discussion: PCPs generally liked the OUD-CDS, but use rates were low, suggesting the need to modify CDS design, implementation strategies and integration with existing primary care workflows. Conclusion: The OUD-CDS tool was functional and accurate, but PCP use rates were low. Despite low use, the OUD-CDS improved confidence in OUD screening, diagnosis and use of buprenorphine. NIH Trial registration NCT03559179. Date of registration: 06/18/2018. URL: https://clinicaltrials.gov/ct2/show/NCT03559179.

Original languageEnglish (US)
Article number37
JournalAddiction Science and Clinical Practice
Volume16
Issue number1
DOIs
StatePublished - Dec 2021
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2021, The Author(s).

Keywords

  • Clinical decision support
  • Opioid use disorder
  • Primary care

Fingerprint

Dive into the research topics of 'A pilot study of the functionality and clinician acceptance of a clinical decision support tool to improve primary care of opioid use disorder'. Together they form a unique fingerprint.

Cite this